HispanicBusiness

Amyris’s initial products include a renewable diesel fuel with performance properties that equal or exceed those of petroleum-sourced fuels and currently available biofuels. A key attribute of the fuel is that it is a hydrocarbon – the same component found in today’s petroleum fuels – enabling it to be used in any kind of diesel engine and withstand extremely low temperatures without the need to alter engines. It can also be easily distributed within the existing fuels infrastructure. In addition to diesel, Amyris expects to produce renewable chemicals for a variety of consumer products and industrial applications currently dependent on petrochemical components.

Amyris applies synthetic biology to alter the metabolic pathways of microorganisms to engineer “living factories” that transform sugar into any one of 50,000 different molecules used in a wide variety of energy, pharmaceutical and chemical applications. Amyris has proven this technology through the delivery of its first successful commercial scale technologies to sanofi aventis for the production of artemisinin, a low cost anti-malarial drug.

About Amyris Biotechnologies:

Amyris Biotechnologies is applying a proprietary synthetic biology technology to create a portfolio of renewable fuels and chemicals that help reduce the world’s carbon footprint. In addition to being environmentally friendly, Amyris products are designed to be low cost, scaleable, and compatible with the existing infrastructure with performance attributes comparable to petroleum-based products. Founded in 2003, Amyris has raised over $125 million in equity funding to date, including investments from Khosla Ventures, Kleiner Perkins Caufield and Byers, TPG Biotech, and Votorantim Novos Negocios. More information about Amyris is available at www.amyris.com.

Amyris operates two subsidiary companies: Amyris Fuels, LLC and Amyris Brasil Pesquisa e Desenvolvimento, Ltda. Amyris Fuels is building Amyris’s U.S. based product distribution and marketing capabilities, generating current revenue from an expanding distribution and customer network. Amyris Brasil was established in March, 2008 to oversee Amyris’s final scale up, licensing, production and distribution in Brazil. Amyris Brasil has approximately 40 employees and facilities in Campinas, Brazil including labs, a pilot plant and demonstration facility. The managing director is Roel Collier, and advisers include Fernando Reinach of Votorantim Novos Negocios and Roberto Rodrigues, former Brazilian minister of agriculture.

Forward-Looking Statements:

The statements contained in this release that are not historical are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 as amended. These include, without limitation, statements regarding scale up, economies and all future performance criteria of Amyris renewable products. Words such as "expect," "believe", "plan" and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon the Company's current expectations. Forward-looking statements involve risks and uncertainties. The Company's actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties.

Photos⁄Multimedia Gallery Available: http:⁄⁄www.businesswire.com⁄cgi-bin⁄mmg.cgi?eid=5995094&lang=en